With positive results from diabetes prevention studies, there is interest in convenient ways to incorporate screening for glucose intolerance into routine care and to limit the need for fasting diagnostic tests.
life expectancy. 2, 3 The annual total cost of diabetes in the USA was estimated at $132 billion in 2002; 4 as the incremental costs of care for patients with diabetes begin to rise during an 8-year period before diagnosis, such estimates are likely too low. 5 Diabetes in its earliest stages is asymptomatic, and clinical recognition is estimated to occur 8-12 years after onset of dysglycemia. 6, 7 As a consequence of the delay in diagnosis, individuals with newly diagnosed diabetes often exhibit early evidence of complications. 8, 9 Moreover, although effective treatment of diabetes can reduce the development of complications 10, 11 , factors such as loss of beta cell mass 12 can make it difficult to normalize glucose levels 13, 14 , and many patients do not meet national standards for control. However, treatment may be more effective if initiated early in the natural history 15 ,
and there is now unequivocal evidence that diabetes itself can be delayed or prevented if glucose intolerance is detected at the stage of "prediabetes"-IGT or IFG. 16, 17 Detection of IGT, IFG, and early diabetes is, thus, clearly desirable, and the National Institutes of Health and the American Diabetes Association have accordingly recommended screening to identify both diabetes and prediabetes. 18 However, most healthcare systems and most individual practitioners do not screen for early diabetes or prediabetes in any formal way. 19 As systematic strategies for screening are still in evolution, it is important to take full advantage of the information in tests for glycemia that are already in widespread use-such as random plasma glucose (RPG). It is also important to limit the need for tests performed in the fasted state, which patients are reluctant to schedule. 20 In a recent study, 70% of primary care patients had some measure of glycemia over a 3-year period, and 95% of the assessments were RPG; 19 RPGs are already being performed nearly routinely in adults at risk for diabetes, and these results could be used more by clinicians to identify a need for further more definitive screening. Many clinicians regard RPG as informative only if values are over 200 mg/dl in the presence of typical symptoms of diabetes. 21 We asked whether lower levels of RPG could be used as an opportunistic "serendipitous screening" strategy to identify individuals with diabetes or prediabetes.
METHODS

Subjects
Between 1 January 2005 and 31 December 2006, 990 subjects from age 18 to 75 took part in the "Screening for Impaired Glucose Tolerance" (SIGT) study. Invitation to participate was extended to employees of the Grady Health System, Emory HealthCare, and Emory University and Morehouse Schools of Medicine, as well as members of the community. Inclusion criteria were no prior diagnosis of diabetes, not pregnant or nursing, not taking glucocorticoids, and being well enough to be able to have worked during the previous week (without requiring actual employment). During the 2-year period, 2,377 individuals expressed initial interest in the study and were appended to the recruitment database, 2,258 could be contacted, 1,302 were scheduled for visits, and 1,060 completed first visits. Of these, 39 declined second visits, 17 were scheduled for but had not had second visits by 31 December 2006, 997 completed both visits, and 990 had data that were largely complete; 989 subjects were used for some analyses.
Protocol
The study was approved by the Emory Institutional Review Board and was performed in General Clinical Research Centers at Emory University Hospital and Grady Memorial Hospital. Random plasma glucose samples were obtained at the first visit, which did not require a prior overnight fast and was scheduled during the work day. The second visit was scheduled within 3 weeks and included a 75-g oral glucose tolerance test (OGTT) begun before 11 AM after an overnight fast. Height was measured with a stadiometer after shoes were removed. Weight was measured using digital scales with subjects in light clothing. Blood pressure was measured with digital manometers after subjects had been seated quietly for 5 minutes. Waist circumference was measured halfway between the costal margin and the iliac crest by trained research interviewers, and sex-adjusted values were expressed relative to cutoffs for the "metabolic syndrome" as defined by the National Cholesterol Education Program (NCEP) 22 criteria.
Subjects also reported their demographic information and family history of diabetes.
Measurements
Plasma samples for glucose were obtained using sodium fluoride/oxalate preservative. These and fasting samples for lipids were centrifuged, separated, and frozen within 30 minutes. Chemical analyses were performed in the central clinical laboratory of the Grady Health System using the BeckmanCoulter LX-20 (Brea, CA). High-density lipoprotein (HDL) cholesterol levels were expressed relative to "metabolic syndrome" cutoffs as above.
Analysis
Normal glucose tolerance (NGT) was defined by the American Diabetes Association (ADA) criteria (fasting glucose <100, 2-hour glucose <140 mg/dl); impaired fasting glucose 100 (IFG 100 ) and impaired fasting glucose 110 (IFG 110 ) by fasting glucose 100-109 and 110-125 mg/dl, respectively, with 2-hour glucose <140 mg/dl; impaired glucose tolerance (IGT) by 2-hour glucose 140-199 with fasting glucose ≤125 mg/dl; and diabetes (DM) by fasting glucose ≥126 or 2-hour glucose ≥200 mg/dl. We focused particularly on diabetes and abnormal glucose tolerance 110 (AGT 110 , diabetes or IGT or IFG 110 ), as such levels confer increased mortality. 23, 24 Receiver operating characteristic (ROC) curve analysis was used to evaluate the discriminative effectiveness of random plasma glucose. The area under the ROC curve (AROC) is the index of effectiveness, with 1.0 indicating perfect discrimination and 0.5 chance discrimination. Bootstrap methodology was applied to assess the over-optimism of sample-calculated AROCs. 25 In this application, 200 bootstrap replicates were drawn (with replacement) to calculate the maximum absolute error in AROCs. Locally weighted least squares regression (LOWESS) was used to assess the relationship between random plasma glucose and postprandial time. To assess the performance of RPG in subgroups with different pretest probability of glucose intolerance, we examined the detection of diabetes/AGT 110 in groups with differences in risk factors such as age, body mass index (BMI), family history of diabetes in a first-degree relative, etc. For each subgroup, we deter-mined the likelihood of having RPG exceeding a cutoff, the likelihood of diabetes/dysglycemia, and AROC for detection of diabetes. Statistical analyses were conducted using S-Plus, version 7 (Insightful, Inc. Seattle, WA) and Stata, version 9 (Stata Corporation, College Station, TX).
RESULTS
The 990 study subjects had an average age of 48 years and BMI of 30.4 kg/m 2 ; 54% were black and 66% were women, and they had an average RPG of 99 mg/dl (Table 1) . Those with NGT tended to be younger and less overweight, with an average RPG of 93 mg/dl. Those with abnormal glucose tolerance were older and heavier but had similar distribution of gender and race. However, those with IFG only were less likely to be black or women, and those with IGT only were more likely to be women. Figure 1 shows greater variability and higher levels of RPG in the first 3-4 hours after meals in subjects with either NGT or AGT 110 (diabetes or IGT or IFG 110 , see Methods). Only 4.7% of NGT subjects had values as high as 125 mg/dl at any postprandial time, whereas 18.5% of AGT 110 subjects had values that high (p<0.001). However, there was substantial overlap in RPG between subjects with NGT and those with glucose intolerance.
Despite such overlap, RPG was a strong indicator of unrecognized glucose intolerance. We used ROC analysis to evaluate the ability of RPG to identify prediabetes 110 (any IGT or IFG 110 ), AGT 110 , and diabetes ( Table 2 shows AROCs at different times after meals and times of day; sensitivities correspond to 70% specificity cutoffs at those times (approximately 112 mg/dl for diabetes and 100 for AGT 110 ; see below). The AROC for RPG to identify unrecognized diabetes was unaffected by postprandial time or time of day. In contrast, the AROC for AGT 110 was also unaffected by postprandial time but reduced later in the day (p<0.0078 for trend; values after 3:30 PM were excluded because of small numbers of subjects in that group). Table 3 shows the performance of RPG as a screen in subgroups with higher or lower pretest probability of having diabetes or glucose intolerance. The likelihood of unrecognized diabetes or AGT 110 was significantly increased by well-accepted risk factors for glucose intolerance. Each factor also contributed to the probability of having RPG >125 mg/dl but did not affect the AROC for RPG to identify unrecognized diabetes. There was no significant difference in AROC whether the risk factor was present or absent and no trend with respect to markers of insulin resistance; AROC was somewhat higher with increased waist circumference but also with normal triglycerides. Thus, the presence of risk factors was associated with a higher prevalence of high glucose levels and would increase the positive predictive value of RPG when used as a screening test but did not modify the ability of the screen to detect diabetes. Results were similar for the impact of risk factors on the RPG AROC to detect AGT 110 (not shown). Table 4 shows the effect of different RPG cutoffs on sensitivity, specificity, and positive predictive value (PPV). The lower cutoffs provide greater sensitivity but reduced PPV because specificity is lower-more false positives; sensitivity is also prevalence independent, but PPV responds to the underlying presence of the abnormalities in the population. In the entire dataset, 62.5% had NGT, 5.0% had diabetes, and 24.0% had AGT 110 . For identification of diabetes, an intermediate cutoff of 125 mg/dl provided 93% specificity, 40% sensitivity, and 22% positive predictive value. The same cutoff provided 94% specificity, 18% sensitivity, and 49% positive predictive value for AGT 110 . Use of a lower cutoff would increase the sensitivity for detection of glucose intolerance, but a lower percentage of those with a positive test would prove to have AGT 110 or diabetes. Conversely, screening with progressively higher RPG cutoffs would provide greater likelihood that diabetes and AGT 110 would be found among those who screened positive (higher positive predictive value) at the cost of reduced sensitivity. Even balance between sensitivity and specificity and a higher product of sensitivity × (1-specificity) would be provided by cutoffs of 100-110 mg/dl for diabetes and 95-100 mg/dl for any glucose intolerance 110 . However, with these lower cutpoints, positive predictive value would be lower, especially for the detection of diabetes, and costeffectiveness might be reduced as well. 26 With the intermediate cutoff, 125 mg/dl, 89 subjects would screen positive, and these would include 40% of those with diabetes and 18% of those with AGT 110 in the entire dataset.
DISCUSSION
We found that RPG functioned well (AROC 0.80) as a screen for undiagnosed diabetes. The performance of the test was good at different times of the day regardless of meal status, and Shown are AROCs corresponding to different times of day and times after meals and sensitivities and specificities corresponding to ∼70% specificity cutoffs at those times (70% specificity cutoffs are approximately 112 for diabetes and 100 for AGT 110 -see Table 4 ).
performance was maintained in the presence or absence of risk factors such as older age, higher BMI, low HDL cholesterol, or high triglycerides or blood pressure. A cutoff of 125 mg/dl had 93% specificity and 40% sensitivity for diabetes. Performance was lower to find abnormal glucose intolerance 110 (AGT 110 , diabetes or IGT, or IFG 110 ), with AROC 0.72. However, AROCs for RPG to detect diabetes and AGT 110 , respectively, were better than those for detection of coronary artery disease by evaluation of coronary artery calcium and treadmill stress tests, respectively. 27 As RPG is included in routine blood chemical analyses, such glucose values could be used to prompt follow-up studies with definitive oral glucose tolerance tests and help to identify early diabetes and prediabetes.
There have been previous considerations of diabetes screening via RPG, but some early workers did not report exclusion of individuals with known diabetes. 28 The Australian Diabetes Screening Study found overlap between normal and diabetes similar to that in the present study and concluded that a cutoff of 99 mg/dl should be used for screening but did not report sensitivity, specificity, or AROC. 29, 30 Johnson et al. 31 reported that a RPG of 130 mg/dl would provide 87% specificity and 63% sensitivity, and Zhang et al. 32 reported that a capillary glucose of 120 mg/dl would provide 89% specificity and 68% sensitivity, consistent with the present findings, but did not perform ROC analysis. Rolka et al. 33 found that a capillary glucose of 120 mg/dl would provide 88-89% specificity and To assess the performance of RPG in subgroups with different pretest probability of glucose intolerance, we examined detection of diabetes/AGT 110 in groups with differences in risk factors such as age, BMI, family history of diabetes in a first-degree relative, etc. For each subgroup, shown are the likelihood of having RPG>125 mg/dl, the likelihood of diabetes/dysglycemia, and AROC for detection of diabetes. With regard to the black race, many blacks were female and had a family history of diabetes in a first-degree relative. In our dataset, women were somewhat less likely to fail the cutoff or to have glucose intolerance; in multivariate analyses adjusted for age, BMI, gender, and family history, black race contributed independently to the risk of the different categories of glucose intolerance (all p<0.03) and also to risk of having RPG>125 (p=0.012). Lower cutoffs provide greater sensitivity but reduced positive predictive value (PPV) since specificity is lower -more false-positives.
70-80% sensitivity to detect diabetes, and 90-91% specificity and 41-47% sensitivity for AGT 110 but did not report AROC. Engelgau et al. 34 reported that the performance of random capillary glucose to identify diabetes was better shortly after meals, a finding not reproduced in the present study. However, as the difference between RPG in diabetes vs. NGT tended to be larger in the first few hours after meals (Fig. 1) , it is possible that the test will be more useful shortly after meals. Better performance has been reported with multivariate equations that include postprandial time as well as random capillary glucose, age, sex, and BMI, 35 but such information is not usually captured when chemistry analyses are performed. Questionnaires based on symptoms and risk factors have also been developed as inexpensive strategies to identify patients who need further evaluation. Although some questionnaires have been reported to provide AROC for diabetes~0.80, [36] [37] [38] comparable to that of screening with RPG, most provide 0.70-0.75, [39] [40] [41] and some that initially appeared promising had lower performance when applied to a separate population in the same city. 42 In the USA, it has been estimated that diabetes goes on for 10 years before clinical recognition, 43 and longer delay leads to higher glucose levels at the time of diagnosis. 44 Delay likely explains why many patients have diabetes complications at the time of diagnosis, 7, 45, 46 with increased cardiovascular risk, 47 and exhibit an increase in cardiovascular events, health care system resource use, and costs before diagnosis. [48] [49] [50] Consistent with such observations, earlier diagnosis appears to lead to improved outcomes. 51 Patients may also be easier to manage if they are recognized earlier in their natural history and have had less loss of β-cell mass and function; 12, 52, 53 although national guidelines for management are not achieved 13, 14 and providers often fail to intensify therapy when indicated, [54] [55] [56] conventional therapies seem to be more effective if initiated earlier in the natural history, 15 and detection at the earliest stage of glucose intolerance-"prediabetes"-is essential to permit initiation of efforts aimed to prevent or delay development of diabetes. 16, 17 Such considerations argue for screening, especially in patients at high risk. 19, 57, 58 The use of RPG in routine chemistry profiles as "serendipitous screening" for diabetes may also be cost effective. For example, use of the 125-mg/dl cutoff in the 990-patient dataset would have resulted in 89 positive tests. If all of these were followed by oral glucose tolerance tests, the added direct costs to identify the included 20 individuals with diabetes-40% of those in the entire dataset-would have been $1,601 at current Medicare rates ($17.99 per OGTT, CPT 82951). 59 The projected added cost of $80 per true positive compares favorably with values reported in analyses of the cost effectiveness of diabetes screening. 31, 32 Although screening should be cost effective, 26, 31, 32, 60 especially if targeted to patients with risk factors such as hypertension 61 , there is little systematic screening at present. While screening programs are being developed, our findings indicate that (a) the plasma glucose values included in routine chemistry profiles could be used as part of a screening strategy, and (b) if individuals with values>125 mg/dl had follow-up glucose tolerance tests (ordered infrequently in the USA but more often in other countries 62 ), the approach might identify many patients with previously unrecognized diabetes and prediabetes.
Limitations of the study include the lack of racial/ethnic groups other than whites and blacks, and the possibility of selection bias because participation was entirely voluntary; the prevalence of undiagnosed diabetes in our subjects was higher than that in NHANES III [5.1% vs. 2.7%, 63 ]. Some subjects may have participated because they were aware of risk factors such as obesity or a family history of diabetes, and our study constituted free screening. However, while any potential selection bias might limit generalizability of positive predictive values, it should have less impact on the use of RPG as a screening test; we found that the presence of abnormal risk factors increased the likelihood of both diabetes and having RPG >125 mg/dl, but the risk factors generally had no effect on the performance of the test. The strengths of the study include the use of a substantial number of generally healthy subjects, the inclusion of subjects both above and below the age recommended for screening 18 , inclusion of a large proportion of women and blacks, and evaluation across a range of diabetes risk factors.
At present, over 5 million Americans have undiagnosed diabetes and many more have "prediabetes," 64, 65 but most health care systems in the USA do not have programs to screen systematically for these problems. While various screening protocols are being evaluated, more use could be made of the RPG measurements that are included in the many blood chemistry profiles that Americans have in the process of routine health evaluations; one large laboratory service provider reported~2.5 million glucose tests per year in metropolitan Atlanta alone (J. Ritchie, personal communication). Our findings demonstrate that RPG could be considered by practitioners to be part of an opportunistic "serendipitous screening" algorithm-to prompt further evaluation with a glucose tolerance test. Whether lower cutoffs are chosen to optimize sensitivity or higher cutoffs to favor specificity, use of an RPG-based strategy could help to identify patients who now have undiagnosed diabetes and prediabetes.
